Aromatic plants extract for pharmaceutical industry Opportunity Description: Aromatic plants extract for pharmaceutical industry as import substitute for local industry which is financially competitive |
|
  PRODUCT: Extracts from caraway, cumin, fennel and hibiscus Sector: Sustainable Agriculture and Food Processing Market: Pharmaceuticals Initial Investment Required: Above 500,000 EGP Details Available: |
|
Market Potential: Sold to Pharmaceutical industry in Lower and Middle Egypt or outside Egypt. Competing products include Synthetic alternatives, imported material. Supply: Supplies from farms in Luxor/Qena, rest of Upper Egypt and the Red Sea, and in the Delta. Required inputs include Aromatic plants (pharmaceutical grade supply). Process: Drying -> mixing and evaporation -> distillation (low temperature, High pressure, purifiers) -> possibly CO2 extraction Human Resources: Manual labour, technical, chemist (or engineers) Financial: CAPEX is above 3m EGP, mainly cost of equipment and licensing OPEX is between 150,000 EGP and 500,000 EGP, processing of material Risk: Perfecting production technique and meeting industry specifications (quality control), licensing of pharmaceutical grade product IMPACT: Environmental - Reliance on green chemicals reduce pollutants of synthetic chemicals Social - Increase value added on agriculture produce, decrease imports of chemicals required for high value-added industry |
unido popup Test
